04/25/2024 3:47 PM | Crinetics Pharmaceuticals (Filer)
| Form DEF 14A | |
04/25/2024 3:48 PM | Crinetics Pharmaceuticals (Filer)
| Form DEFA14A | |
04/25/2024 3:50 PM | Crinetics Pharmaceuticals (Filer)
| Form ARS | |
04/22/2024 4:23 PM | Crinetics Pharmaceuticals (Issuer) Struthers Richard Scott (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/17/2024 3:30 PM | Crinetics Pharmaceuticals (Issuer) Struthers Richard Scott (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/17/2024 3:36 PM | Crinetics Pharmaceuticals (Issuer) Pizzuti Dana (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/08/2024 4:09 PM | Crinetics Pharmaceuticals (Issuer) Struthers Richard Scott (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
|
04/04/2024 3:52 PM | Crinetics Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/04/2024 3:17 PM | Crinetics Pharmaceuticals (Subject) Struthers Richard Scott (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/26/2024 3:30 PM | Crinetics Pharmaceuticals (Issuer) Knight Jeff E. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/22/2024 3:31 PM | Crinetics Pharmaceuticals (Issuer) Fust Matthew K (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/22/2024 1:34 PM | Crinetics Pharmaceuticals (Subject) Knight Jeff E. (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/21/2024 4:20 PM | Crinetics Pharmaceuticals (Subject) Knight Jeff E. (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/20/2024 5:31 PM | Crinetics Pharmaceuticals (Issuer) Struthers Richard Scott (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/20/2024 5:32 PM | Crinetics Pharmaceuticals (Issuer) Wilson Marc (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/20/2024 5:33 PM | Betz Stephen F. (Reporting) Crinetics Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/20/2024 5:34 PM | Crinetics Pharmaceuticals (Issuer) Hassard James (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/20/2024 5:35 PM | Crinetics Pharmaceuticals (Issuer) Knight Jeff E. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/20/2024 5:36 PM | Crinetics Pharmaceuticals (Issuer) Pizzuti Dana (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/20/2024 4:37 PM | Crinetics Pharmaceuticals (Subject) Fust Matthew K (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/20/2024 3:40 PM | Crinetics Pharmaceuticals (Subject) Pizzuti Dana (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/19/2024 5:31 AM | Crinetics Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/11/2024 3:15 PM | Crinetics Pharmaceuticals (Filer)
| Form D Notice of Exempt Offering of Securities | |
03/11/2024 2:34 PM | Crinetics Pharmaceuticals (Subject) EcoR1 Capital, LLC (Filed by)
| Form SC 13G | |
03/06/2024 7:18 PM | Crinetics Pharmaceuticals (Issuer) Hassard James (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/06/2024 6:59 PM | Crinetics Pharmaceuticals (Issuer) Knight Jeff E. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/06/2024 7:00 PM | Crinetics Pharmaceuticals (Issuer) Pizzuti Dana (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/06/2024 7:01 PM | Crinetics Pharmaceuticals (Issuer) Struthers Richard Scott (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/06/2024 7:01 PM | Crinetics Pharmaceuticals (Issuer) Wilson Marc (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/06/2024 6:57 PM | Betz Stephen F. (Reporting) Crinetics Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/01/2024 7:05 PM | Crinetics Pharmaceuticals (Subject) PERCEPTIVE ADVISORS LLC (Filed by)
| Form SC 13D/A | |
03/01/2024 3:41 PM | Crinetics Pharmaceuticals (Filer)
| Form S-8 POS | |
02/28/2024 3:31 PM | Crinetics Pharmaceuticals (Subject) Krasner Alan Seth (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/14/2024 5:36 PM | Crinetics Pharmaceuticals (Subject) ORBIMED ADVISORS LLC (Filed by)
| Form SC 13G/A | |
02/14/2024 6:54 AM | Crinetics Pharmaceuticals (Subject) DRIEHAUS CAPITAL MANAGEMENT LLC (Filed by)
| Form SC 13G/A | |
02/09/2024 7:50 AM | Crinetics Pharmaceuticals (Subject) FMR LLC (Filed by)
| Form SC 13G | |
01/26/2024 4:50 PM | Betz Stephen F. (Reporting) Crinetics Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/24/2024 9:28 AM | Crinetics Pharmaceuticals (Subject) STATE STREET CORP (Filed by)
| Form SC 13G | |
01/12/2024 3:12 PM | Betz Stephen F. (Reporting) Crinetics Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/10/2024 11:10 AM | Betz Stephen F. (Reporting) Crinetics Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/08/2024 7:03 AM | Crinetics Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
The biggest energy story ever? (Ad) Discover why I’m calling this one of the biggest developments in the global energy market since the shale revolution… why everything you’ve ever been told about Trump’s environmental record is a lie… For the full story, click here. |
01/04/2024 3:43 PM | Crinetics Pharmaceuticals (Issuer) Wilson Marc (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/04/2024 3:45 PM | Crinetics Pharmaceuticals (Issuer) Pizzuti Dana (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/02/2024 3:44 PM | Crinetics Pharmaceuticals (Subject) Wilson Marc (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/27/2023 4:20 PM | Betz Stephen F. (Reporting) Crinetics Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/26/2023 10:47 AM | Betz Stephen F. (Reporting) Crinetics Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/22/2023 5:45 PM | Crinetics Pharmaceuticals (Issuer) Pizzuti Dana (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/21/2023 4:28 PM | Crinetics Pharmaceuticals (Subject) Pizzuti Dana (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/14/2023 3:37 PM | Crinetics Pharmaceuticals (Subject) Krasner Alan Seth (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/13/2023 3:44 PM | Betz Stephen F. (Reporting) Crinetics Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/12/2023 3:35 PM | Crinetics Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/11/2023 12:48 PM | Betz Stephen F. (Reporting) Crinetics Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
11/29/2023 3:31 PM | Betz Stephen F. (Reporting) Crinetics Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/27/2023 10:40 AM | Betz Stephen F. (Reporting) Crinetics Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
11/13/2023 3:33 PM | Crinetics Pharmaceuticals (Issuer) Struthers Richard Scott (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/07/2023 3:31 PM | Crinetics Pharmaceuticals (Filer)
| Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
11/06/2023 5:02 PM | Crinetics Pharmaceuticals (Issuer) Struthers Richard Scott (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/03/2023 6:38 PM | Crinetics Pharmaceuticals (Issuer) Wilson Marc (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/01/2023 3:44 PM | Crinetics Pharmaceuticals (Subject) Wilson Marc (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
10/19/2023 4:01 PM | Crinetics Pharmaceuticals (Issuer) Krasner Alan Seth (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/17/2023 3:20 PM | Crinetics Pharmaceuticals (Subject) Krasner Alan Seth (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/18/2023 3:24 PM | Crinetics Pharmaceuticals (Subject) Point72 Asset Management, L.P. (Filed by)
| Form SC 13G | |
09/13/2023 4:19 PM | Crinetics Pharmaceuticals (Filer)
| Form 424B5 | |
09/13/2023 4:23 PM | Crinetics Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/11/2023 3:09 PM | Crinetics Pharmaceuticals (Filer)
| Form 424B5 | |
09/11/2023 5:05 AM | Crinetics Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/16/2023 3:30 PM | Crinetics Pharmaceuticals (Issuer) Struthers Richard Scott (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/08/2023 6:01 AM | Crinetics Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/08/2023 6:07 AM | Crinetics Pharmaceuticals (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
07/13/2023 3:14 PM | Crinetics Pharmaceuticals (Subject) Struthers Richard Scott (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
07/12/2023 3:25 PM | Crinetics Pharmaceuticals (Subject) Struthers Richard Scott (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
07/11/2023 3:39 PM | Crinetics Pharmaceuticals (Subject) Struthers Richard Scott (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/21/2023 4:32 PM | Crinetics Pharmaceuticals (Issuer) Wilson Marc (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/21/2023 4:27 PM | Crinetics Pharmaceuticals (Issuer) Struthers Richard Scott (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/21/2023 4:00 PM | Bedrosian Camille L (Reporting) Crinetics Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/21/2023 4:00 PM | Crinetics Pharmaceuticals (Issuer) Fust Matthew K (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/21/2023 4:00 PM | Crinetics Pharmaceuticals (Issuer) Nichols Weston (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/21/2023 4:00 PM | Crinetics Pharmaceuticals (Issuer) Okey Stephanie (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/21/2023 4:00 PM | Crinetics Pharmaceuticals (Issuer) WIERENGA WENDALL (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/21/2023 4:00 PM | Crinetics Pharmaceuticals (Issuer) Deardorf Caren (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/21/2023 4:00 PM | Crinetics Pharmaceuticals (Issuer) Vivaldi Coelho Rogerio (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/21/2023 3:36 PM | Crinetics Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/20/2023 6:07 PM | Crinetics Pharmaceuticals (Subject) Wilson Marc (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/16/2023 3:32 PM | Crinetics Pharmaceuticals (Subject) Struthers Richard Scott (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/09/2023 7:00 AM | Crinetics Pharmaceuticals (Issuer) Vivaldi Coelho Rogerio (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |